Intercept Pharmaceuticals, Inc.

PRINCIPAL FINANCIAL GROUP INC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/2/2023

Shares

39,832

Value ($000)

738

Weight

0.0%

2014 Q1 - 2023 Q3 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/2/2023	738	0.0%	39,832	9/30/2023
2023 Q2	8/7/2023	306	0.0%	27,646	6/30/2023
2023 Q1	5/9/2023	265	0.0%	19,753	3/31/2023
2022 Q4	2/9/2023	284	0.0%	22,948	12/31/2022
2022 Q3	11/9/2022	276	0.0%	19,791	9/30/2022
2022 Q2	8/10/2022	584	0.0%	42,322	6/30/2022
2022 Q1	5/9/2022	1,041	0.0%	63,994	3/31/2022
2021 Q4	2/9/2022	1,544	0.0%	94,811	12/31/2021
2021 Q3	11/9/2021	1,368	0.0%	92,092	9/30/2021
2021 Q2	8/10/2021	1,873	0.0%	93,796	6/30/2021
2021 Q1	5/10/2021	2,226	0.0%	96,431	3/31/2021
2020 Q4	2/23/2021	2,201	0.0%	89,115	12/31/2020
2020 Q3	11/6/2020	2,518	0.0%	60,736	9/30/2020
2020 Q2	8/5/2020	1,916	0.0%	40,000	6/30/2020
2020 Q1	5/12/2020	521	0.0%	8,275	3/31/2020
2019 Q4	2/5/2020	995	0.0%	8,032	12/31/2019
2014 Q1	5/13/2014	4,445	0.0%	13,478	3/31/2014